Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00166179 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI

A clinical trial of Coronary Artery Disease, sponsored by Emory University.

Completed
Registry status
57
Enrollment target
1
Study location

NCT00166179: Completed study of Coronary Artery Disease, sponsored by Emory University.

NCT00166179 is a study of Coronary Artery Disease that has completed, run by Emory University. The registered enrollment target is 57 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00166179, a study of Coronary Artery Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
57 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

Conditions Studied

Study Locations (1)

Georgia

  • Crawford Long Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2003-11
Est. Completion 2006-10
Emory University

1,208 total trials

What the finished NCT00166179 record still lists

NCT00166179 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00166179 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00166179 about?

NCT00166179 is a clinical study titled "Magnetic Resonance Imaging (MRI) Viability: Comparison of Myocardial Viability by Positron Emission Tomography and MRI". The purpose of this study is to compare cardiac MRI with positron emission tomography (PET) with fluorodeoxyglucose (FDG) to determine if cardiac MRI images are as good as, or better, than PET with FDG.

What is the current status of trial NCT00166179?

This trial is currently completed. The enrollment target is 57 participants. The study started on 2003-11. Estimated completion is 2006-10.

What conditions does trial NCT00166179 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00166179?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00166179 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00166179's enrollment target sits among peer trials

57 175th of 219 higher than 45 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00166179, the US trial registry maintained by the National Library of Medicine. NCT00166179 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.